MANTOVANI, GIOVANNA
MANTOVANI, GIOVANNA
Dipartimento di Scienze Cliniche e di Comunità
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma
2025 E. Nozza, E. Emanuela, G. Di Muro, S. Di Bari, R. Catalano, G. Lopez, V. Vaira, A.M. Barbieri, G. Marra, M. Federica, T. Donatella, M. Battistin, Di Dalmazi Guido, S. Palmieri, F. Emanuele, G. Mantovani, E.M. Peverelli
La gestione terapeutica dell’ipoparatiroidismo: tra terapia convenzionale e nuove prospettive
2025 G. Del Sindaco, G. Mantovani
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade
2025 G. Fiore, G.A. Bertani, S.E. Baldeweg, A. Borg, G. Conte, N. Dorward, E. Ferrante, Z. Hussein, A. Miserocchi, K. Miszkiel, G. Mantovani, M. Locatelli, H.J. Marcus
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells
2025 D. Treppiedi, S. Di Bari, F. Mangili, A.M. Barbieri, G. Di Muro, M. Locatelli, A. Mangone, E. Peverelli, G. Mantovani
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
2025 R. Catalano, E. Nozza, B. Altieri, E. Esposito, G.A. Croci, A.M. Barbieri, D. Treppiedi, S. Di Bari, O. Kimpel, M. Detomas, M. Tamburello, M.P. Schauer, S. Herterich, A. Angelousi, M. Luconi, L. Canu, G. Nesi, C. Hantel, S. Sigala, L. Landwehr, G. Di Dalmazi, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, C.L. Ronchi, G. Mantovani, E. Peverelli
Neurofibromatosis type I (NF1) and bone involvement in a pediatric setting: insights from FGF23 levels
2025 G. Rodari, V. Citterio, M. Ikehata, D. Mattinzoli, G. Scuvera, F. Grilli, E. Profka, F. Giacchetti, V. Collini, A. Risio, C. Cesaretti, F. Natacci, C. Alfieri, G. Mantovani, C. Giavoli
Recurrent hyponatremia due to syndrome of inappropriate antidiuresis after traumatic brain injury: two case reports
2025 I. Petria, R. Indirli, B. Mantovani, V. Lanzi, G. Mantovani, E. Ferrante
Skipping of Exon 20 in EP300: A Novel Variant Linked to Rubinstein-Taybi Syndrome With Atypical and Severe Clinical Manifestations
2025 L. Pavinato, S. Carestiato, S. Trajkova, L. Sorasio, G. Mantovani, L. De Sanctis, J. Kerkhof, H. Mcconkey, J. Rzasa, E. Todd, M. Balzo, S. Cardaropoli, A. Bruselles, S. De Rubeis, J.D. Buxbaum, M. Tartaglia, B. Sadikovic, G.B. Ferrero, A. Brusco
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Who and how to screen for endogenous hypercortisolism in patients with mood disorders
2025 E. Ferrante, C. Simeoli, G. Mantovani, R. Pivonello
Sexual health in adult women with complete androgen insensitivity syndrome: a single centre cross-sectional study
2025 A. Mangone, E. Profka, G. Rodari, C. Giavoli, G. Mantovani
Germline-derived GNAS-Gsα variants associated with both gain-of-function and loss-of-function phenotypes
2025 A. Carcavilla, A. Pereda, M. Miyado, M. Fukami, F. Kato, T. Sengoku, K. Ogata, M. Clemente, I. Valenzuela, G. Mantovani, M. Cappa, P. Cavarzere, Y. Vado, I. González-Casado, T. Ogata, G. Perez De Nanclares
Sequential Treatment for Osteoporosis After Teriparatide: A Real-Life Long-Term Comparison Between Zoledronic Acid and Denosumab
2025 A. Ghielmetti, G. Grassi, M. Zampogna, G. Mantovani, I. Chiodini, C. Eller-Vainicher
The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets
2025 R. Catalano, E. Nozza, E. Esposito, S. Di Bari, G. Mantovani, E. Peverelli
Adrenalectomy reduces the risk of vertebral fractures in patients with mild autonomous cortisol secretion
2025 V. Morelli, V. Favero, S. Frigerio, C. Aresta, F. Pugliese, A.S. Salcuni, A. Risio, C. Eller-Vainicher, S. Palmieri, E. Cairoli, S. Corbetta, G. Mantovani, A. Scillitani, I. Chiodini
AZD1775: effect of monotherapy or EDP-M combination in the treatment of ACC preclinical models
2025 E. Nozza, R. Catalano, G. Di Muro, S. Di Bari, G. Lopez, G. Marra, E. Esposito, F. Mangili, D. Treppiedi, M. Battistin, G. Mantovani, E. Peverelli
Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls
2025 G. Grassi, M. Zampogna, A. Atlasova, S. Rondinella, A. Ghielmetti, G. Siracusano, I. Chiodini, G. Mantovani, C. Eller-Vainicher
Hormone replacement in disorders of sex development, and long-term effects
2025 A. Nordenström, A. Mangone, G. Mantovani
Potential antitumoral effects through modulation of VEGF-A splicing in rat somatotroph and lactotroph pituitary tumoral cells
2024 D. Treppiedi, S. Di Bari, F. Mangili, G. Marra, A.M. Barbieri, F. Arlati, M. Locatelli, A. Lania, E. Peverelli, G. Mantovani
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells
2024 G. Di Muro, R. Catalano, D. Treppiedi, A.M. Barbieri, F. Mangili, G. Marra, S. Di Bari, E. Esposito, E. Nozza, A. Lania, M. Locatelli, D. Modena, C. Steinkuhler, E. Peverelli, G. Mantovani